Targeting the endothelin axis in human melanoma: Combination of endothelin receptor antagonism and alkylating agents

Experimental Biology and Medicine

Volumn 231, Issue 6, 2006, Pages 1111-1119

  Berger, Yann ^a   Bernasconi, Catherine Chapuis ^a   Juillerat Jeanneret, Lucienne ^a  

^a UNIVERSITY INSTITUTE OF PATHOLOGY   (Switzerland)

Author keywords

Alkylating agents; Apoptosis; Bosentan; Endothelin axis; Fas ligand; Melanoma

Indexed keywords

ALKYLATING AGENT; BOSENTAN; ENDOTHELIN 1; ENDOTHELIN RECEPTOR ANTAGONIST;

APOPTOSIS; CELL PROLIFERATION; CONFERENCE PAPER; DNA SYNTHESIS; HUMAN; HUMAN CELL; MELANOMA; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ALKYLATING AGENTS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL LINE, TUMOR; CELL SURVIVAL; DACARBAZINE; DRUG DELIVERY SYSTEMS; DRUG SYNERGISM; ENDOTHELIN-1; FAS LIGAND PROTEIN; HUMANS; MELANOMA; MEMBRANE GLYCOPROTEINS; OLIGOPEPTIDES; PEPTIDES, CYCLIC; PIPERIDINES; RECEPTOR, ENDOTHELIN A; RECEPTOR, ENDOTHELIN B; RNA, MESSENGER; SULFONAMIDES; TUMOR NECROSIS FACTORS; VARIATION (GENETICS);

EID: 33744931372     PISSN: 15353702     EISSN: 15353699     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (29)

1. Arai H, Hori S, Aramori I, Ohkubo H, Nakanishi S. Cloning and expression of a cDNA encoding an endothelin receptor. Nature 348: 730-732, 1990.
2. Sakurai T, Yanagisawa M, Takuwa Y, Miyazaki H, Kimura S, Goto K, Masaki T. Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptor. Nature 348:732-735, 1990.
3. 6-methylguanine-DNA-methyltransferase by promoter hypermethylation is a common event in primary human neoplasms. Cancer Res 59:793-797, 1999.
4. Esteller M, Garcia-Foncillas J, Andion E, Goodman SN, Hidalgo OF, Vanaclocha V, Baylin SB, Herman JG. Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents. New Eng J Med 343:1350-1354, 2000.
5. Egidy G, Peduto Eberl L, Valdenaire O, Irmler M, Majdi R, Diserens AC, Fontana A, Janzer RC, Pinet F, Juillerat-Jeanneret L. The endothelin system in human glioblastoma. Lab Invest 80:1681-1689, 2000.
6. Peduto Eberl L, Valdenaire O, SaintGiorgio V, Jeannin JF, Juillerat-Jeanneret L. Endothelin receptor blockade potentiates FasL-induced apoptosis in rat colon carcinoma cells. Int J Cancer 86:182-187, 2000.
7. Peduto Eberl L, Egidy G, Pinet F, Juillerat-Jeanneret L. Endothelin receptor blockade potentiates FasL-induced apoptosis in colon carcinoma cells via the protein kinase C-pathway. J Cardiovasc Pharm 36:S354-S356, 2000.
8. Peduto Eberl L, Bovey R, Juillerat-Jeanneret L. Endothelin-receptor antagonists are proapoptotic and antiproliferative in human colon cancer. Br J Cancer 88:788-795, 2003.
9. Berger Y, Dehmlow H, Blum-Kaelin D, Kitas EA, Löffler BM, Aebi J, Juillerat-Jeanneret L. Endothelin-converting-enzyme-1 inhibition and growth of human glioblastoma cells. J Med Chem 48:483-498, 2005.
10. Bullani RR, Wehrli P, Viard-Leveugle I, Rimoldi D, Cerottini JC, Saurat JH, Tschopp J, French LE. Frequent down regulation of Fas (CD95) expression and function in melanoma. Melanoma Res 12:263-270, 2002.
11. Nelson JB, Lee WH, Nguyen SH, Jarrard DF, Brooks JD, Magnuson SR, Opgenorth TJ, Nelson WG, Bova GS. Methylation of the 5′ CpG island of the endothelin B receptor gene is common in human prostate cancer. Cancer Res 57:35-37, 1997.
12. Pao MM, Tsutsumi M, Liang G, Uzvolgyi E, Gonzales FA, Jones PA. The endothelin receptor B (EDNRB) promoter displays heterogeneous, site-specific methylation patterns in normal and tumor cells. Hum Mol Gen 10:903-910, 2001.
13. Elshourbagy NA, Adamou JE, Gagnon AW, We HL, Pullen M, Nambi P. Molecular characterization of a novel human endothelin receptor splice variant. J Biol Chem 271:25300-25307, 1996.
14. Jeronimo C, Henrique R, Campos PF, Oliveira J, Caballero OL, Lopes C, Sidransky D. Endothelin B receptor gene hypermethylation in prostate adenocarcinoma. J Clin Pathol 56:52-55, 2003.
15. Bagnato A, Rosano L, Spinella F, DiCastro V, Tecce R, Natali PG. Endothelin B receptor blockade inhibits dynamics of cell interactions and communications in melanoma cell progression. Cancer Res 64: 1436-1443, 2004.
16. Lahav, R, Heffner G, Patterson PH. An endothelin receptor B antagonist inhibits growth and induces cell death in human melanoma cells in vitro and in vivo. Proc Nat Acad Sci U S A 96:11496-11500, 1999.
17. Lahav, R, Suva ML, Rimoldi D, Patterson PH, Stamenkovic I. Endothelin receptor B inhibition triggers apoptosis and enhances angiogenesis in melanoma. Cancer Res 64:8945-8953, 2004.
18. Eberle J, Weitmann S, Thieck O, Pech H, Paul M, Orfanoc CE. Downregulaion of endothelin B receptor in human melanoma cell lines parallel to differentiation genes. J Invest Dermatol 112:925-932, 1999.
19. Demunter A, De Wolf-Peeters C, Degreef H, Stas M, van den Oord JJW. Expression of the endothelin-B receptor in pigment cell lesions of the skin. Evidence for its role as tumor progression marker in malignant melanoma. Virchows Arch 438:485-491, 2001.
20. Clozel M, Löffler BM, Breu V, Hilfiger L, Maire JP, Butscha B. Down regulation of endothelin receptors by autocrine production of endothelin-1. Am J Physiol 265:C188-C192, 1993.
21. Paasche JD, Attramadal T, Sandberg C, Johansen HK, Attramadal H. Mechanisms of endothelin receptor subtype-specific targeting in distinct intracellular trafficking pathways. J Biol Chem 276:34041-34050, 2001.
22. Eberle J, Fecker LF, Orfanos CE, Geilen CC. Endothelin-1 decreases basic apoptosis rates in human melanoma cell lines. J Invest Dermatol 119:549-555, 2002.
23. Ohtani T, Ninomiya H, Okazawa M, Imamura S, Masaki T. Bromodeoxyuridine-induced expression of endothelin A in A-375 human melanoma cells. Biochem Biophys Res Comm 234:526-530, 1997.
24. Okazawa M, Shiraki T, Ninomiya H, Kobayashi S, Masaki T. Endothelin-induced apoptois of A-375 human melanoma cells. J Biol Chem 273:12584-12592, 1998.
25. Takai D, Yagi Y, Wakazono K, Ohishi N, Morita Y, Sugimura T, Ushijima T. Silencing of HTR1B and reduced expression of EDN1 in human lung cancers, revealed by methylation-sensitive representational difference analysis. Oncogene 20:7505-7513, 2001.
26. Zhang YF, Jeffery S, Burchill SA, Berry PA, Kaski JC, Carter ND. Truncated human endothelin receptor A produced by alternative splicing and its expression in melanoma. Br J Cancer 78:1141-1146, 1998.
27. Shyamala V, Moulthrop THM, Stratton-Thomas J, Tekamp-Olson P. Two distinct human endothelin B receptors generated by alternative splicing from a single gene. Cell Mol Biol Res 40:285-296, 1994.
28. Tsutsumi M, Liang G, Jones PA. Novel endothelin B receptor transcripts with the potential of generating a new receptor. Gene 228: 43-49, 1999.
29. B) receptor is cleaved by a metalloprotease in an agonist-dependent process. J Biol Chem 277: 42933-43941, 2002.